Used in the treatment of Parkinson’s disease, this compound acts as a dopamine agonist, stimulating dopamine receptors in the brain to help control movement and reduce symptoms such as tremors, stiffness, and slowness of movement. It is particularly effective in managing motor fluctuations in patients on long-term levodopa therapy. The compound is also investigated for use in restless legs syndrome due to its action on central nervous system pathways. Its extended-release formulation allows for once-daily dosing, improving patient compliance.